| 1 |
Nesterova IV, Atazhakhova MG, Teterin YV, Matushkina VA, Chudilova GA, Mitropanova MN. THE ROLE OF NEUTROPHIL EXTRACELLULAR TRAPS (NETS)
IN THE IMMUNOPATHOGENESIS OF SEVERE COVID-19: POTENTIAL IMMUNOTHERAPEUTIC STRATEGIES REGULATING NET FORMATION AND ACTIVITY. Russian Journal of Infection and Immunity 2023. [DOI: 10.15789/2220-7619-tro-2058] [Reference Citation Analysis]
|
| 2 |
Goma TV, Kalyagin AN, Ryzhkova OV, Soloveva NS. Efficacy of olocizumab in treatment of COVID-19 patients. Acta biomedica scientifica 2022;7:86-95. [DOI: 10.29413/abs.2022-7.5-2.9] [Reference Citation Analysis]
|
| 3 |
Muravyeva NV, Belov BS. Interleukin-6 inhibitors: from the therapy of immuno-inflammatory rheumatic diseases to use in COVID-19. Medicinskij sovet 2022. [DOI: 10.21518/2079-701x-2022-16-11-88-94] [Reference Citation Analysis]
|
| 4 |
Orlova EV, Lyamina NP, Skorobogatyth NV, Pogonchenkova IV. Сlinical Efficacy of Individually Dosed Intermittent Hypoxia-Hyperoxic Therapy in Osteoarthritis Patients with Post-Covid Syndrome. Bulletin of Rehabilitation Medicine 2022;21:6-16. [DOI: 10.38025/2078-1962-2022-21-2-6-16] [Reference Citation Analysis]
|
| 5 |
Nasonov EL, Lila AM, Dubinina TV, Nikininskaya OA, Amirdjanova VN. Advances in rheumatology at the beginning of the 21st century. Naučno-praktičeskaâ revmatologiâ 2022;60:5-20. [DOI: 10.47360/1995-4484-2022-5-20] [Reference Citation Analysis]
|
| 6 |
Litvinova MA, Muravyeva NV, Belov BS. COVID-19 Therapy: the Role of Antirheumatic Drugs. A&Ch 2021;66:83-89. [DOI: 10.37489/0235-2990-2021-66-7-8-83-89] [Reference Citation Analysis]
|
| 7 |
Nasonov EL, Lila AM, Mazurov VI, Belov BS, Karateev AE, Dubinina TV, Nikitinskaya OA, Baranov AA, Abdulganieva DI, Moiseev SV, Zagrebneva AI. Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia. Naučno-praktičeskaâ revmatologiâ 2021;59:239-254. [DOI: 10.47360/1995-4484-2021-239-254] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 8 |
Rumiantceva DG, Urumova MM, Erdes SF. New coronavirus infection COVID-19 as a trigger for the development of symptoms of ankylosing spondylitis. Case report. Terapevticheskii arkhiv 2021;93. [DOI: 10.26442/00403660.2021.05.200793] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 9 |
Ershov AV, Surova VD, Dolgikh VT, Dolgikh TI. Cytokine Storm in the Novel Coronavirus Infection and Methods of its Correction. A&Ch 2021;65:27-37. [DOI: 10.37489/0235-2990-2020-65-11-12-27-37] [Reference Citation Analysis]
|
| 10 |
Nasonov EL. Coronavirus disease-2019 (COVID-19): value of IL-6 inhibitors. Pulʹmonologiâ (Mosk ) 2020;30:629-44. [DOI: 10.18093/0869-0189-2020-30-5-629-644] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 11 |
Nasonov EL, Beketova TV, Reshetnyak TM, Lila AM, Ananieva LP, Lisitsyna TA, Soloviev SK. Coronavirus disease 2019 (COVID-19) and immune-mediated inflammatory rheumatic diseases: at the crossroads of thromboinflammation and autoimmunity. Naučno-praktičeskaâ revmatologiâ 2020;58:353-67. [DOI: 10.47360/1995-4484-2020-353-367] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 12 |
Nasonov EL, Lila AM. BARICITINIB: NEW PHARMACOTHERAPY OPTIONS FOR RHEUMATOID ARTHRITIS AND OTHER IMMUNE-MEDIATED INFLAMMATORY RHEUMATIC DISEASES. Naučno-praktičeskaâ revmatologiâ 2020;58:304-16. [DOI: 10.14412/1995-4484-2020-304-316] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
